• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Modern Prometheus: Editing the Human Genome with Crispr-Cas9

Modern Prometheus: Editing the Human Genome with Crispr-Cas9

9781107172166
157,44 zł
141,69 zł Zniżka 15,75 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 141,69 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
Would you change your genes if you could? As we confront the industrial revolution of the genome, the recent discoveries of Crispr-Cas9 technologies are offering, for the first time, cheap and effective methods for editing the human genome. This opens up startling new opportunities as well as significant ethical uncertainty. Tracing events across a fifty-year period, from the first gene splicing techniques to the present day, this is the story of gene editing - the science, the impact and the potential. Kozubek weaves together the fascinating stories of many of the scientists involved in the development of gene editing technology. Along the way, he demystifies how the technology really works and provides vivid and thought-provoking reflections on the continuing ethical debate. Ultimately, Kozubek places the debate in its historical and scientific context to consider both what drives scientific discovery and the implications of the commodification of life.
Szczegóły produktu
64128
9781107172166
9781107172166

Opis

Rok wydania
2016
Numer wydania
1
Oprawa
twarda
Liczba stron
395
Wymiary (mm)
152.00 x 228.00
Waga (g)
880
  • 1. Crispr, Cas and capitalists; 2. The gene trade; 3. Asilomar; 4. We can play God in that cell; 5. Modern Prometheus; 6. Biopolitics; 7. Life in a bubble; 8. To summon a Leviathan; 9. A molecular fairytale; 10. Secrets from a freshwater fish; 11. Gene hackers; 12. Washington.
Komentarze (0)